Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hyster-Yale (HY) Cash & Equivalents (2016 - 2021)

Historic Cash & Equivalents for Hyster-Yale (HY) over the last 11 years, with Q3 2021 value amounting to $61.4 million.

  • Hyster-Yale's Cash & Equivalents fell 3170.19% to $61.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $61.4 million, marking a year-over-year decrease of 3170.19%. This contributed to the annual value of $151.4 million for FY2020, which is 13436.53% up from last year.
  • Per Hyster-Yale's latest filing, its Cash & Equivalents stood at $61.4 million for Q3 2021, which was down 3170.19% from $87.5 million recorded in Q2 2021.
  • In the past 5 years, Hyster-Yale's Cash & Equivalents ranged from a high of $239.9 million in Q2 2017 and a low of $50.3 million during Q2 2019
  • Its 5-year average for Cash & Equivalents is $115.1 million, with a median of $87.5 million in 2021.
  • Per our database at Business Quant, Hyster-Yale's Cash & Equivalents surged by 40949.07% in 2017 and then crashed by 7558.09% in 2019.
  • Hyster-Yale's Cash & Equivalents (Quarter) stood at $220.1 million in 2017, then crashed by 61.97% to $83.7 million in 2018, then decreased by 22.82% to $64.6 million in 2019, then soared by 134.37% to $151.4 million in 2020, then crashed by 59.45% to $61.4 million in 2021.
  • Its Cash & Equivalents stands at $61.4 million for Q3 2021, versus $87.5 million for Q2 2021 and $103.0 million for Q1 2021.